L.J. Altfest & Co’s Celgene Corp CELG Stock Holding History

L.J. Altfest & Co’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,234	Closed	-$335K	–	194
2018 Q4	$335K	Sell	5,234 -265	-5%	-$19.6K	0.09%	110
2018 Q3	$492K	Sell	5,499 -42	-0.8%	-$3.71K	0.14%	107
2018 Q2	$440K	Hold	5,541	–	–	0.16%	112
2018 Q1	$494K	Sell	5,541 -5,437	-50%	-$522K	0.21%	105
2017 Q4	$1.15M	Buy	10,978 +6,865	+167%	+$775K	0.44%	53
2017 Q3	$600K	Hold	4,113	–	–	0.29%	87
2017 Q2	$534K	Sell	4,113 -246	-6%	-$30.1K	0.32%	90
2017 Q1	$542K	Buy	4,359 +4	+0.1%	+$479	0.22%	82
2016 Q4	$504K	Hold	4,355	–	–	0.25%	81
2016 Q3	$455K	Buy	4,355 +77	+2%	+$8.33K	0.3%	78
2016 Q2	$422K	Buy	+4,278	New	+$443K	0.29%	84
2016 Q1	–	Sell	-4,346	Closed	-$520K	–	100
2015 Q4	$520K	Hold	4,346	–	–	0.51%	57
2015 Q3	$470K	Hold	4,346	–	–	0.46%	60
2015 Q2	$503K	Hold	4,346	–	–	0.46%	60
2015 Q1	$501K	Hold	4,346	–	–	0.47%	57
2014 Q4	$486K	Buy	+4,346	New	+$458K	0.4%	69
2014 Q2	–	Sell	-4,342	Closed	-$297K	–	106
2014 Q1	$297K	Buy	4,342 +96	+2%	+$7.6K	0.28%	83
2013 Q4	$359K	Buy	+4,246	New	+$336K	0.31%	77

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

L.J. Altfest & Co's CELG Position: Q1 2019 in Review

L.J. Altfest & Co sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 5,234 shares — an estimated $335K sold.

L.J. Altfest & Co first reported a position in CELG in Q4 2013 and held it in 18 quarters. The position peaked at $1.15M in Q4 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

L.J. Altfest & Co reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
L.J. Altfest & Co sold 5,234 Celgene Corp shares in Q1 2019, an estimated $335K.
L.J. Altfest & Co first reported a position in Celgene Corp in Q4 2013 and held it in 18 quarters.
L.J. Altfest & Co's Celgene Corp position peaked at $1.15M in Q4 2017.
1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on L.J. Altfest & Co's 13F filing for Q1 2019, filed 5 Apr 2019.